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INTRODUCTION:  Leiomyoma  is the most  common  benign  tumor  of the  esophagus  (67–80%),  it  represents
0.4–1%  of  all  esophageal  tumors.
PRESENTATION  OF  CASE:  An incidentally  discovered  gastro-esophageal  submucosal  tumor  was  found  to
have increased  ﬂuorine-18-ﬂuorodeoxyglucose  (FDG)  uptake  on  positron  emission  computed  tomogra-
phy (PET/CT).  After  laparoscopic  surgical  exploration  and  local  enucleation  the tumor  turned  out  to  be  a
benign  esophageal  leiomyoma.
DISCUSSION:  There  are  few  reports  of  esophageal  leiomyomas  with  a  positive  uptake  on  (PET/CT)  and
even  fewer  adopting  our  combination  of  a minimally  invasive  approach  and  frozen  section  examinationositron-emission tomography
inimally invasive surgery
as  a management  plan.  Our  approach  avoided  excessive  morbid  surgical  resections  and  underestimation
of  a malignant  disease.
CONCLUSION: We  report  this  case  hoping  to  expand  the  existing  literature  on the  topic  and  to  highlight
the  limitations  of PET/CT  in guiding  the  diagnosis  and  subsequently  the  management  of  esophageal
submucosal  tumors.
©  2014  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Leiomyoma is the most common benign tumor of the esophagus
67–80%); it represents 0.4–1% of all esophageal tumors.1
Its differential diagnosis should be established with gastroin-
estinal stromal tumors (GIST), and other benign tumors. The
riteria to resect or not a leiomyoma is based on the symptoms it
roduces, especially dysphagia, and on the need to exclude malig-
ancy. Positron emission computed tomography (PET/CT) using
uorine-18-ﬂuorodeoxyglucose (FDG) provides information on tis-
ue metabolic activity and can help in the differential diagnosis.
We  report a case of esophageal submucosal tumor that showed
 markedly increased FDG uptake on initial preoperative workup
ET/CT. Based on this information we opted for a surgical mini-
nvasive exploration.∗ Corresponding author. Tel.: +32 2 541 31 69; fax: +32 2 541 31 41.
E-mail address: issam.elnakadi@bordet.be (I.E. Nakadi).
ttp://dx.doi.org/10.1016/j.ijscr.2014.06.013
210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical A
http://creativecommons.org/licenses/by-nc-nd/3.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
2. Presentation of case
A 54 year old man  was admitted to another hospital for abdom-
inal trauma following a motor vehicle accident. His past medical
history includes hepatic steatosis secondary to excess alcohol
intake but no history of tobacco smoking.
On admission a thoraco-abdominal CT showed several fractured
ribs, an incidental gastro-esophageal tumor and a ruptured spleen
for which the patient underwent a splenectomy via open midline
laparotomy.
The tumor was  described as a bulky partially calciﬁed mass
measuring 45 × 52 × 29 mm,  poorly vascularized and seemingly
extrinsic to the esophageal lumen coming in contact with the ante-
rior pericardium (Fig. 1). Radiological diagnosis was that of a likely
malignant process. Multiple celiac lymph nodes were also noted,
the largest measuring 16 mm.
Following the patient’s postoperative recovery, a follow-up CT
showed the same unchanged celiac lymph nodes and an increase
in size of 4 mm  of the previously described tumor.Further investigations included an upper endoscopy conﬁrming
the submucosal location of the tumor. An endoscopic ultra-
sonography (Fig. 2) disclosed a heterogeneous submucosal tumor
with well-deﬁned margins in the muscularis mucosa located at
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Fig. 1. Admission CT-scan showing the gastro-esophageal calciﬁed mass (white
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Final histo-pathological result showed macroscopically a
5 × 3 × 5 × 3 cm white homogenous mass with a lobulated aspect.
Microscopically, the resected specimen showed intercrossingrrow) along with the perisplenic collection (red arrow).
5–40 cm from the dental arcade. This mass was hypoechoic
ith multiple hyperechoic foci inside of it. A differential diag-
osis of degenerated GIST versus leiomyoma/leiomyosarcoma or
ost-traumatic hematoma was made. No abnormal lymph nodes
ere detected. After undergoing the above mentioned investiga-
ions namely the endoscopic ultrasound and both abdomino-pelvic
omodensitometries the patient was referred to our institute for
urther management.
A PET/CT scan (Fig. 3) showed an abnormally increased FDG
ptake (SUV = 6.1) in the tumor with no other metabolically active
esion detected. Both the elevated SUV and the tomodensitomet-
ic appearance were more in favor of a malignant process. A Fine
eedle Aspiration (FNA) was performed after the positive PET/CT
esult to rule out a malignancy and was inconclusive.Fig. 2. Endoscopic ultrasound showing the submucosal tumor with well-deﬁned
margins in the muscularis mucosa (black arrow).
To avoid both, missing a malignant disease and unnecessary
large surgical procedures, we opted for a minimally invasive
surgical exploration guided by frozen section. The different
resection possibilities, tumorectomy or partial esogastrectomy
with Merendino reconstruction or radical esophagogastrectomy,
were comprehensively explained to the patient.
The operation was started with the patient in the supine posi-
tion. Laparoscopic exploration of the abdominal cavity showed no
gross anomalies except the adhesions from the previous splenec-
tomy.
Liberation of the abdominal esophagus and progressive dissec-
tion of the thoracic esophagus revealed a multi-lobulated lesion
adherent to the esophagus. This tumor was  progressively dissected
from the esophageal muscular layers under direct endoscopic con-
trol.
The mass was then extracted in an endo-bag via a small mid-
line laparotomy using the superior part of the existing splenectomy
incision, intraoperative histo-pathological examination revealed a
benign esophageal leiomyoma. A Nissen fundoplication was per-
formed to cover the esophageal sub-mucosa.
The postoperative course was  uneventful with a normal gastro-
graﬁn swallow done at day 4.Fig. 3. FDG-F-18 PET/CT scan showed an abnormally increased FDG uptake (arrow-
head) at the level of the lesion described above.
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tFig. 4. Pathology slides showing nodular hyperplasia fo
mooth muscle ﬁbers with no nuclear anomalies and minimal
nﬂammatory focal inﬁltration; ﬁndings characteristic of a leiomy-
ma  (Figs. 4 and 5). Immunohistochemical examination also
emonstrated negative reactivity for CD117 (c-kit proto-oncogene
roduct), CD34, MIB-1, and glucose transporter-1 (GLUT-1) along
ith the absence of mutation in c-kit or platelet-derived growth
actor receptor, allowing us to rule out a gastrointestinal stromal
umor.
Fig. 5. Magniﬁed view of Fig. 4 showing ovoid nucleus (by the intercrossing smooth muscle cells (black circle).
3. Discussion
Esophageal leiomyoma is a rare ﬁnding (0.4–1% of all esophageal
tumors).1 Endoscopy typically reveals a submucosal mass with
intact mucosa.2 Preoperative diagnosis of leiomyoma relies on
many imaging techniques such as endoscopic ultrasonography
that shows a homogeneous and hypoechoic lesion with clear
margin.3–5 CT scan ideally completes the preoperative evaluation of
arrow), and eosinophilic cytoplasm (arrowhead).
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able 1
ases of esophageal leiomyoma with positive FDG PET/CT uptake, the surgical approach; mini-invasive vs open was  also precised.
Cases Positive PET/CT uptake Mini-invasive approach Open approach Number of cases
Depypere et al.14 Yes YES 2
Miyoshi et al.15 Yes YES 1
Meirelles et al.16 Yes YES 1
Lee  et al.17 Yes YES 1
Our  case Yes YES 1
he patients, revealing in most cases a mass originating from esoph-
gus without lymphadenopathies. In our case, CT-scan showed
nlarged celiac lymph nodes.
Preoperative biopsy of the tumor is a debating issue. Some argue
hat it can render enucleation more difﬁcult also FNA entails the risk
f esophageal leak or ﬁstula with a risk of potential mediastinitis.6–8
Positron emission tomography (PET) with a labeled glucose ana-
og, F18-ﬂuorodeoxyglucose (FDG) is a valuable diagnostic tool that
s widely used to survey malignant and inﬂammatory disease.9
DG-PET is an imaging modality for abnormality of function or
etabolism in tissue and organs, which usually precedes anatomic
hange. FDG accumulation has already been described in cases of
terine leiomyomas10 and in patients with esophageal and genital
eiomyomatosis.11
Abnormal FDG accumulation in the esophagus can be explained
y many non-oncological inﬂammatory conditions such as: gastro-
sophageal reﬂux, Barrett esophagus, acanthosis and infection.12 It
ould be wise to correlate an incidental FDG uptake with CT-scan
ndings in the gastro-esophageal junction.13
To our knowledge, there have been 4 reports (5 cases) of pos-
tive FDG-PET in the case of isolated benign lower esophageal
eiomyoma.14–17 Kentaroh Miyoshi’s reported case15 was  enucle-
ted through thorascopy and a mini-thoracotomy. The 2 cases
eported at Leuven14 were excised via a left thoracotomy [Table 1].
About 0.2% of leiomyomas show a malignant transformation to
eiomyosarcoma.18 The management of asymptomatic esophageal
eiomyomas is non-surgical. However in our case, the suspicion of
alignancy following chest CT ﬁndings and the FDG uptake on
he PET scanner imposed a surgical option. With the ﬁnding of
sophageal leiomyoma on frozen section exam, laparoscopic enu-
leation was the most reasonable and least morbid option in our
ase. The minimally invasive approach versus the open one offers
onsiderable advantages including reduced pain, better respiratory
unction, shorter hospital stay, faster return to regular activities,
nd esthetic of the surgical wound.19,20
A high index of suspicion is demanded when dealing with
ositive FDG-PET/CT of the lower esophagus. One should always
ake into account the macroscopic aspect as well as the results
of the various imaging techniques available such as endoscopy,
ultrasonography, CT or MRI, laparoscopy and frozen section exam-
ination.
4. Conclusion
When dealing with an asymptomatic submucosal esophageal
lesion with an abnormally increased uptake on PET/CTFDG scan-
ner, this paper indicates that integrating all results of different
imaging techniques does not allow an accurate diagnosis and an
exploratory minimally invasive approach combined with a frozen
section examination can potentially avoid excessive morbid surgi-
cal resections and particularly an underestimation of a malignant
disease.
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Key learning points
• Minimal invasive approach combined with a frozen section can avoid excessive surgical resection and underestimation
of malignant disease in positive PET/CTFDG submucosal esophageal lesion.
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